This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Primary outcome was new-onset CVD (self-reported heart disease/stroke) based on survey data at Wave 2 (2012–2015) and/or Wave 3 (2018–2020). Methods The Sax Institute’s 45 and Up Study prospectively recruited participants aged ≥45 years (n=267 357) between 2005 and 2009 (New South Wales, Australia).
Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. Patients with RP-HCM showed the poorest outcomes, with a follow-up mortality rate of 42.86%. Only 10.4% (22/212) of patients underwent genetic testing, yet the positive detection rate was 63.7% (14/22).ConclusionsThis
The TACT2 study was designed to replicate the results of a previous trial, TACT , which reported in 2012 that chelation reduced subsequent cardiovascular events after a heart attack. Food and Drug Administration to treat lead poisoning, but studies investigating its use for other conditions have yielded mixed results.
MSSP was introduced in 2012 to improve care quality and lower Medicare costs by having ACOs assume responsibility for Medicare beneficiaries costs and care quality. As an incentive, Medicare then makes fee-for-service payments and shares the savings with ACOs if cost and care quality benchmarks are met.
This American Heart Association scientific statement serves as an update to the 2012 statement on the evaluation and management of neurodevelopmental outcomes in children with congenital heart disease.
The research team analyzed deaths after PCI occurring at 39 Michigan hospitals participating in BMC2 between 2012 and 2014. These hospitals use procedural and outcome data to inform quality projects to improve care and patient outcomes. For more information: [link] If you enjoy this content, please share it with a colleague
Methods and results A systematic search of electronic databases (PubMed, EMBASE, CENTRAL) identified randomized controlled trials from January 2012 to June 2023, comparing non-invasive RPM interventions for HF with usual care. A random-effects meta-analysis assessed outcomes, and additional analyses identified effective RPM components.
The analysis included 4,798 patients from 207 STS sites who underwent esophagectomy between 2012-2019. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.
Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Outcomes were worse with increasing surgical urgency, older age, dialysis dependence, and multiple reoperations.
The aim of this study was to investigate the association of preoperative imaging and haemodynamic data derived from echocardiography (ECHO), cardiac magnetic resonance (CMR) and right heart catheterisation (RHC) with postoperative outcomes following TVS. The primary outcome was a composite of mortality and congestive heart failure at 1 year.
BackgroundNontraumatic subarachnoid hemorrhage (SAH) presents a significant health burden, yet the influence of social determinants of health on outcomes remains unclear. Outcomes included inhospital death, length of stay, and discharge disposition (good: home/rehabilitation; poor: longterm facility/hospice/death).
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
Guideline-directed medical therapy (GDMT) for HF has shown benefits on outcomes. Methods and results Between 2012 and 2023, 408 patients admitted for HF with a LV ejection fraction (LVEF) of 40% or less and documented coronary artery disease (CAD) were included. After a median 44.6-month
This study aimed to assess whether statin use could lead to better outcomes among individuals with AF.Methods and ResultsWe enrolled 397 787 patients with AF from January 1, 2012 to December 31, 2020.
We aimed to evaluate whether proteinuria in young people is associated with an increased risk of SCA.Methods and ResultsIndividuals aged between 20 and 39 years who underwent health screening between 2009 and 2012 in South Korea were included (n=6 891 400). Urine protein was measured using the spot urine dipstick method.
This combination is often extremely effective for maintaining good longterm outcome ( Lanza and Shimokawa — Eur Cardiol 18: e38, 2023 ). Final Thoughts: Today's patient was discharged and treated with a calcium blocker and extended release nitroglycerin.
We used an independent BBJ2 (BBJ second cohort; recruited between 2012 and 2017, n=41 929) as a test sample to evaluate the association of the metaGRS with stroke and recurrent stroke. The outcomes derived from these examinations did not provide any significant indication of the influence of index event bias.
This study analyzes the association between the hospital policy on local anesthesia (LA) versus general anesthesia, and the outcome of elective CEA in German hospitals.MethodsThis retrospective analysis is based on the nationwide German statutory carotid quality assurance database for the years 2012 to 2016.
Striving for the best outcomes and understanding optimal surgical techniques continue to be at the forefront of discussion and research. This study presents a single-center experience of cervically cannulated neonatal patients on V-A ECMO, a description of our cannulation/decannulation techniques and our patient outcomes.
This study aims to evaluate the safety of combined intracranial vessel stent placement and thrombolysis.Methods:We conducted a retrospective analysis of patients with large vessel occlusion who underwent rescue stent angioplasty after stent-retriever thrombectomy between 2012 and 2023 in 8 neurovascular centers. 10.43, p=0.0325).Conclusions:The
This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2012) 380:2095128. For more information on Revolution Vibe, please visit gehealthcare.com. i Revolution Vibe is CE marked and 510(k) pending with theU.S.FDA. Eur J Radiol.
A prior published analysis of national trends after one year in mechanical thrombectomy use and outcomes for stroke before and after publication of the 2015 US guideline update showed improved functional outcomes and lower peri‐procedural mortality. Safety outcomes include in‐hospital medical complications and mortality.
BACKGROUNDVascular tortuosity affects the outcomes of mechanical thrombectomy (MT). The 3‐month modified Rankin scale, procedural outcomes, and post‐MT intracranial hemorrhage were assessed.RESULTSA total of 106 patients with basilar artery occlusion were included. Clinical and procedure‐related factors were obtained.
Methods Medical records and CT angiograms of all patients hospitalised for acute aortic dissection in the Stockholm County during the 5-year period 2012–2016 were reviewed. The patients were followed until date of death or until 31 December 2020. The annual incidence was determined.
We determined the utility of this score for predicting outcomes within one-year post-stroke/TIA.Methods:Analysis of adults with acute stroke/TIA (2012-2016) using linked data from the Australian Stroke Clinical Registry and administrative datasets (pharmaceutical, hospital, Medicare), as part of the PRECISE study.
Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. Patients included were of Hispanic origin presenting between 2012 and 2022 who underwent thrombectomy for acute ischemic stroke. or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Circulation: Cardiovascular Interventions, Ahead of Print.
The present study aimed to validate the proposed algorithm by the American Heart Association (AHA‐2022) considering cardiovascular findings and outcomes in kidney transplant candidates, and to compare AHA‐2022 with the previous recommendation (AHA‐2012).Methods 10.8]; and HR, 2.1 [95% 3.9]) and all‐cause death (HR, 12.0 [95%
ABSTRACT Aims There are few prospective reports of 1-year outcomes for women with peripartum cardiomyopathy (PPCM). Methods and results The registry enrolled women from 51 countries from 2012 to 2018. We report findings from the European Society of Cardiology EURObservational Research Programme PPCM Registry.
Data regarding demographics, indications, diagnosis, echocardiographic findings, postoperative complications, hospital stay, and outcomes were recorded.ResultsA total of 143 patients underwent pulmonary artery banding between 2000 and 2020, with a decrease from approximately 15 surgeries per year in 2012 to 1–2 surgeries a year in 2020.
2012 Apr;67(4):395-405. There is very little we can do to avoid these outcomes, but we can set the odds in our favour to delay the onset of the major chronic disease that is likely to be our cause of death. 2012 Apr;67(4):395-405. But let’s look at WHEN centenarians get these diseases. J Gerontol A Biol Sci Med Sci.
The evolving trends in the approaches and outcomes of RFCA of LVS-VAs at a single center were evaluated.METHODS:We studied 88 consecutive patients with idiopathic LVS-VAs at our institute from 2009 to 2019. These patients were divided into 3 periods: 2009 to 2012 (early), 2013 to 2015 (middle), and 2016 to 2019 (recent).
Catheters were stratified based on construction materials, tip technology, catheter sizing, and catheter lining. Factors associated with first pass effect (FPE ‐ first‐pass eTICI2c‐3 reperfusion) as well as speed of clot engagement were analyzed.ResultsWe identified 983 patients with proximal occlusion and aspiration as the first pass technique.
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE).
Objective This study aimed to assess the diagnostic value of prenatal echocardiography for identifying transposition of the great arteries (TGA) during pregnancy and evaluating the associated outcomes. This analysis included prenatal ultrasound, prenatal screening, clinical management and follow-up procedures.
Methods We included all adult patients with severe SMR due to left ventricle dysfunction (with no organic mitral valve disease) who underwent transthoracic echocardiography between January 2012 and March 2021 at our institution. They underwent fewer MV interventions, although these were associated with better outcomes (log-rank p<0.001).
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Treatment effects are expressed as an odds ratio for a better health status outcome with an invasive versus conservative treatment strategy using Bayesian hierarchical proportional odds models. Diabetes was present in 28% and multivessel disease in 51%.
Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrial fibrillation / flutter, incident myocardial infarction or all-cause mortality. Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrial fibrillation / flutter, incident myocardial infarction or all-cause mortality.
A bare metal stent (BMS) may protect LGO, according to the hypothesis of this single-center retrospective analysis.MethodsAll patients undergoing elective EVAR with a bifurcated stent graft between January 2012 and June 2022 were included in this cohort study. In contrast, group B consisted of those who did not receive a BMS.
Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials.” Archives of cardiovascular diseases 105 4 (2012): 226-38.) Let’s do a meta-analysis” Even meta-analysis couldn’t help out rhythm control strategy.
Short-term outcomes include in-hospital mortality and 28-day mortality. Multivariable Cox regression analyses were constructed to assess the relationship between AG and short-term outcomes in sepsis patients complicated by PH.Results:2012 sepsis patients with pulmonary hypertension were included. According to the AG value (17.0
Background:A novel inflammatory score has been validated for hematoma expansion and poor outcomes in patients with intracerebral hemorrhage. Logistic regression models were used for exploring the association between inflammatory score and hemorrhagic transformation and poor outcomes.
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content